CSIMarket Company Name, Ticker, Industry, else..


Denali Therapeutics Inc   (NASDAQ: DNLI)
Other Ticker:  
 

Denali Therapeutics Inc

DNLI's Fundamental analysis



Denali Therapeutics Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1721

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Denali Therapeutics Inc net loss decreased from $-199 millions, to $-107 millions in III. Quarter 2024,

• More on DNLI's Growth


Denali Therapeutics Inc
realized a net loss in trailing twelve months.

Denali Therapeutics Inc realized cash reduction of $ -0.34 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.61.


• More on DNLI's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 7.78

Denali Therapeutics Inc
realized net loss in trailing twelve months.

Denali Therapeutics Inc realized cash outflow of $ -0.34per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.61.

Denali Therapeutics Inc Price to Book Ratio is at 2.86 lower than Industry Avg. of 471.45. and higher than S&P 500 Avg. of 0.01

• More on DNLI's Valuation

•  Market Capitalization (Millions $) 3,765
•  Shares Outstanding (Millions) 169
•  Employees 445
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -366
•  Cash Flow (TTM) (Millions $) -57
•  Capital Exp. (TTM) (Millions $) -13
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 7.78

•  Market Capitalization (Millions $) 3,765
•  Shares Outstanding (Millions) 169
•  Employees 445
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -366
•  Cash Flow (TTM) (Millions $) -57
•  Capital Exp. (TTM) (Millions $) -13





  Ratio
•   Capital Ratio (MRQ) 9.98
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.1
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com